Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
118F-AV-1451----[3] 5, 7, 127
218F-FDG[1] Fludeoxyglucose (18F)---[13] 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300
318F-RO6958948----[3] 5, 7, 127
4ABBV-8E12----[2] 5, 7
5AL----[10] 5, 7, 13, 28, 51, 67, 86, 97, 114, 127
6Anti-Parkinson medication----[5] 5, 6, 7, 8, 17
7Apomorphine[1] Apomorphine[2] D02004 ,
D07460 		[2] DRD1,
DRD2 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 5, 6, 7
8BIIB092----[3] 5, 7, 127
9BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
10Brain PET scan----[3] 5, 7, 127
11Davunetide[1] Davunetide[1] D09401 --[3] 5, 7, 127
12Davunetide (AL-108, NAP)[1] Davunetide[1] D09401 --[3] 5, 7, 127
13Deep Brain Stimulation----[5] 5, 6, 7, 8, 17
14Diagnostic Test: [18F]-RO6958948----[5] 5, 6, 7, 17, 127
15Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau----[5] 5, 6, 7, 17, 127
16Diagnostic Test: Flutemetamol F18 Injection[2] Flutemetamol,
Flutemetamol (18F)		---[5] 5, 6, 7, 17, 127
17Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau----[5] 5, 6, 7, 17, 127
18Dopamine[1] Dopamine[2] D00633 ,
D07870 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 7, 74
19Fasudil[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 2, 5, 7, 51
20Flortaucipir[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
21Flortaucipir F18[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
22Flutemetamol[1] Flutemetamol (18F)---[5] 5, 6, 7, 17, 127
23Flutemetamol F18[1] Flutemetamol (18F)---[5] 5, 6, 7, 17, 127
24Leucine[1] Leucine[1] D00030 --[11] 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299
25Lithium[1] Lithium citrate[1] D04749 --[5] 2, 5, 6, 7, 8
26NT 101----[4] 5, 6, 7, 17
27Other: 13C6 Leucine[1] Leucine[1] D00030 --[3] 5, 7, 127
28Raclopride[1] Raclopride---[4] 5, 6, 7, 17
29TPI 287 2 mg/m2----[2] 5, 7
30TPI-287 20 mg/m2----[2] 5, 7
31TPI-287 6.3 mg/m2----[2] 5, 7
32Vizamyl[1] Flutemetamol (18F)---[3] 5, 7, 127
33Vizamyl (flutemetamol(F-18))[2] Flutemetamol,
Flutemetamol (18F)		---[3] 5, 7, 127
34Xeomin[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[7] 5, 6, 7, 13, 15, 17, 113